Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

IDX/INAF stock hub

IDX/INAF has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

IDX/INAFis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

390.5B

Indonesia Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

IDX/INAF

In the news

Latest news · IDX/INAF

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 9.4P50 14.4P75 23.9

Trailing P/En/a

P25 11.5P50 23.8P75 52.6

ROEn/a

P25 0.6P50 5.1P75 12.2

ROICn/a

P25 1.3P50 6P75 11.8

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All IDX/INAF market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

167

Groups with data

Currency

IDR

Showing 167 of 167 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Indonesia
Country code	ID
Employees	21
Employees Change	-767%
Employees Change Percent	-97.34
Enterprise value	IDR 952.4B
Exchange	Indonesia Stock Exchange
Financial currency	IDR
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	ID1000068406
Last refreshed	2026-05-10
Market cap	IDR 390.5B
Price	IDR 126
Price currency	IDR
Rev Per Employee	9,821,166,219.52x
Sector	Healthcare
Sic	2834
Symbol	idx/INAF
Website	https://indofarma.id

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-75.57%
EV Earnings	-3.23x
EV/Sales	4.62x
P/B ratio	-0.44x
P/S ratio	1.89x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-115.51%
EBITDA Margin	-108.47%
Gross margin	-20.1%
Gross Profit	IDR -41.5B
Net Income	IDR -295.1B
Net Income Growth Quarters	6%
Net Income Growth Years	1%
Pretax Margin	-113.99%
Profit Margin	-143.08%
Profit Per Employee	IDR -14.1B
ROA	-22.22
Roa5y	-12.49
ROCE	35.27

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-2.84%
Cagr15y	2.08%
Cagr1y	-79.93%
Cagr20y	3.01%
Cagr3y	-65.65%
Cagr5y	-43.95%
Div CAGR10	-23.43%
Div CAGR3	-58.92%
Div CAGR5	-41.37%
EPS Growth Quarters	6
EPS Growth Years	1
Revenue Growth	-4.41x
Revenue Growth Q	136.95x
Revenue Growth Years	0x
Revenue Growth3 Y	-55.3x
Revenue Growth5 Y	-32.98x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	IDR 0.31
Assets	IDR 581.6B
Cash	IDR 34.7B
Current Assets	IDR 164.5B
Current Liabilities	IDR 1.3T
Debt	IDR 845.7B
Equity	IDR -890.9B
Liabilities	IDR 1.5T
Long Term Assets	IDR 417.1B
Long Term Liabilities	IDR 215.4B
Net Cash	IDR -811.1B
Net Cash By Market Cap	IDR -208
Tangible Book Value	IDR -892.8B
Tangible Book Value Per Share	IDR -288
WACC	1.84

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.13
Inventory Turnover	4.94
Net Working Capital	IDR -497B
Quick ratio	0.08
Working Capital	IDR -1.1T
Working Capital Turnover	IDR -0.18

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0%
Dividend per share	IDR 0
Last Dividend	IDR 1.37

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-25%
1Y total return	-80%
200-day SMA	399.2
3Y total return	-95.95%
50-day SMA	179.5
50-day SMA vs 200-day SMA	50under200
5Y total return	-94.47%
All Time High	7,350
All Time High Change	-98.29%
All Time High Date	2021-01-12
All Time Low	50
All Time Low Change	152%
All Time Low Date	2008-10-27
ATR	6.29
Beta	0.28
Beta1y	0
Beta2y	0.27
Ch YTD	-78.28
High	126
High52	725
High52 Date	2023-12-21
High52ch	-82.62%
Low	126
Low52	126
Low52 Date	2024-07-01
Low52ch	0%
Ma50ch	-29.81%
Price vs 200-day SMA	-68.43%
RSI	24.56
RSI Monthly	30.01
RSI Weekly	30.11
Sharpe ratio	-2.37x
Sortino ratio	-2.99
Total Return	-0%
Tr YTD	-78.28
Tr15y	36.15%
Tr1m	-38.24%
Tr1w	-7.35%
Tr3m	-59.35%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	IDR -238.2B
Operating margin	-115.5

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Net Borrowing	173,014,662,425
Shares Institutions	7.34%
Shares Out	3,099,267,500
Shares Qo Q	0%
Shares Yo Y	0%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	65,400x
Bv Per Share	-287.5
Ch10y	-25
Ch15y	35.48
Ch1m	-38.24
Ch1w	-7.35
Ch1y	-80
Ch20y	80
Ch3m	-59.35
Ch3y	-95.95
Ch5y	-94.47
Ch6m	-78.28
Change	0%
Close	126
Depreciation Amortization	14,519,598,416
Earnings Date	2026-04-30
EBIT	IDR -238.2B
EBITDA	IDR -223.7B
EPS	IDR -95.22
F Score	4
Financing CF	173,014,662,425
Fiscal Year End	December
Founded	1,918
Income Tax	IDR 60B
Investing CF	92,824,965
Is Primary Listing	1
Last Earnings Date	2025-10-31
Last Report Date	2025-09-30
Ma150	367.3
Ma150ch	-65.7%
Ma20	155.5
Ma20ch	-18.97%
Net CF	27,796,214,864
Open	0
Ppne	328,214,415,078
Price Date	2024-07-01
Relative Volume	47.25x
Revenue	206,244,490,610x
Tax By Revenue	29.09x
Tr20y	80.89%
Tr6m	-78.28%
Volume	0
Z Score	-6.81

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does IDX/INAF pay a dividend?

Capital-return profile for this ticker.

Performance

IDX/INAF stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns IDX/INAF?

Insider, institutional, and short-interest positioning.

Institutional ownership

+7.3%

Share of float held by funds and institutions

Insider ownership

n/a

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+0.0%

Negative means the company is buying back shares.

Technical

IDX/INAF momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

24.6

Below 30: short-term oversold

Price vs 200-day MA

-68.4%

50/200-day relationship not available

Beta (5Y)

0.28

Less volatile than the market

Sharpe ratio

-2.37

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About IDX/INAF

Hub-level FAQ points readers to the deeper analysis pages.

What is the current idx/INAF stock rating?

idx/INAF is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full idx/INAF analysis?

The full report lives at /stocks/idx/INAF/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for idx/INAF?

The latest report frames idx/INAF around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the idx/INAF page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.